Supplementary Figure 5 from Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2<sup>−/−</sup>IL2Rγ<sup>null</sup> Immunodeficient Mice | Publicación